Concepedia

Alan V. Boddy

AV

134

Publications

6.5K

Citations

45

H-Index

1989

Active since

Affiliations

Newcastle University(Current)

The University of Sydney

Cancer Research UK

Freeman Hospital

University of South Australia

Alan V. Boddy is an author at Newcastle University specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1989–2022

134

Publications

134

Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors

Ruth Plummer, Christopher J. Jones, Mark R. Middleton et al. · Clinical Cancer Research · 2008 · 380 citations · Full text

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

Ruth Plummer, Richard H. Wilson, Hilary Calvert et al. · British Journal of Cancer · 2011 · 378 citations · Full text

Phase I and pharmacokinetic study of d -limonene in patients with advanced cancer

David M. Vigushin, Grace K. Poon, Alan V. Boddy et al. · Cancer Chemotherapy and Pharmacology · 1998 · 240 citations

, , +7

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

Johanne Bray, J Sludden, Martin J. Griffin et al. · British Journal of Cancer · 2010 · 179 citations · Full text

Estimation of glomerular filtration rate in cancer patients

Jackson Wright, Alan V. Boddy, Martin Highley et al. · British Journal of Cancer · 2001 · 169 citations · Full text

Rows per page

1–5 of 134